Virtual Presentation

Treatment of Cutaneous T-Cell Lymphoma: Focus on Relapsed/Refractory Disease

Source: Treatment of Cutaneous T-Cell Lymphoma: Focus on Relapsed/Refractory Disease

Treatment of Cutaneous T-Cell Lymphoma: Focus on Relapsed/Refractory Disease

Faculty:

John A. Zic, MD
Timothy Kuzel, MD

CREDIT INFORMATION

Release Date: August 01, 2006

Expiration Date: July 31, 2007

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Define cutaneous T-cell lymphoma and describe the elements necessary for a proper diagnosis of the disease, including the variants mycosis fungoides and Sézary syndrome
Review the various stages of cutaneous T-cell lymphomas and their prognostic significance
Discuss treatment options for patients with previously treated, and treatment-refractory cutaneous T-cell lymphoma

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.